Non-Invasive Glucose Detection via Angular Light Scattering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for monitoring blood glucose levels are invasive, inconvenient, or suffer from poor signal-to-noise ratios, making continuous and non-invasive monitoring challenging.

Innovation Solution

A non-invasive method utilizing the angular dependence of scattered light components to determine substance concentration in a particle-containing liquid, specifically leveraging the refractive index changes caused by glucose concentration in blood, through the detection of forward and backward scattered light components.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If invasive techniques (finger prick or needle sensor) are used to measure blood glucose, then measurement precision is improved, but ease of operation deteriorates due to repeated skin penetration

Engineering Contradiction:
Improveblood glucose measurement precisionVSAvoidease of continuous monitoring
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent replaces mechanical/invasive measurement systems (finger prick, needle sensor) with an optical measurement system that uses light scattering to detect glucose concentration in interstitial fluid, enabling non-invasive continuous monitoring

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent uses interstitial fluid as an intermediary medium to indirectly measure blood glucose levels, avoiding direct blood sampling while still obtaining accurate glucose concentration data through optical measurement of the fluid between cells

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If optical IR measurements are used for non-invasive glucose monitoring, then ease of operation is improved, but measurement precision deteriorates due to difficulties in emitter and detector selection

Engineering Contradiction:
Improvenon-invasive measurement capabilityVSAvoidblood glucose measurement precision
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent changes the measurement parameter from direct IR absorption to light scattering intensity at specific angles, using the angular distribution of scattered light as a new parameter that provides more reliable glucose concentration information

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent adds the angular dimension to light detection by measuring scattered light at multiple angles (including forward scattering), transforming a one-dimensional absorption measurement into a multi-dimensional scattering measurement that improves precision

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Ease of operation

If Raman spectroscopy is used for non-invasive glucose monitoring, then ease of operation is improved, but measurement precision deteriorates due to very poor signal-to-noise ratio

Engineering Contradiction:
Improvenon-invasive measurement capabilityVSAvoidsignal-to-noise ratio
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent changes the detection parameter from Raman scattering intensity to Mie scattering angular distribution, using the angle-dependent scattering pattern as a new parameter that provides stronger signal and better signal-to-noise ratio for glucose detection

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables continuous, non-invasive monitoring of blood glucose levels by effectively utilizing the angular dependence of scattered light to infer refractive index changes, improving upon existing invasive and noisy measurement techniques.

Implementation Method 1

The invention also makes use of the fact that the distribution of the scattered light is influenced, among other things, by a scattering similar to Mie scattering, since the particles contained in the liquid are of the same order of magnitude as a wavelength of a measuring light beam.

Methodology Applied
Scientific EffectMie scattering: Scattering

Implementation Method 2

a refractive index of the liquid is dependent on a concentration of the substance dissolved therein

Methodology Applied
Scientific EffectRefraction: Refraction

Data Source

PatentUS20250040841A1Method for determining the concentration of a substance and detector arrangment
Publication Date: 2025.02.06 AMS OSRAM INT GMBH
  • US20250040841A1 patent drawing
  • US20250040841A1 patent drawing
  • US20250040841A1 patent drawing

AI summary

A method for determining a substance concentration in a particle-containing liquid, in particular of glucose in blood, wherein a refractive index of the liquid is dependent on a concentration of the substance dissolved therein, includes emitting a measuring light beam of at least one wavelength onto a sample containing the liquid. The method also includes detecting a first light component scattered by scattering on the particles contained in the liquid at a first angle, which corresponds in particular to a forward scattering of the light component. The method further includes detecting a second light component scattered at a second angle by the particles contained in the liquid. The method additionally includes determining a concentration or a proportion of the substance in the liquid from the detected first and second light components, in particular by forming a ratio from the detected first and second light components.